chiara paratore

[Massimo Di Maio @MassimoDiMaio75]

#ASCO24 have a look at our poster by @chiaramallow "Health-related quality of life (QoL) in randomized phase III trials in oncology: Association between results of QoL, results of primary endpoint and drug approval."
Poster board #304

[Massimo Di Maio @MassimoDiMaio75]

Is the control arm of RCTs always optimal?
Look at our study just published in Eur J Cancer
@OncoAlert
(1/6)

Analysis of the adequacy of control arms in oncology randomized clinical trials published between 2017 and 2021: a meta-research study https://t.co/QS5Ampo1Vl

[Massimo Di Maio @MassimoDiMaio75]

Have a look at our systematic review of subgroup analyses in randomized trials in oncology, by @chiaramallow, Clizia Zichi et al, just published in @ESMO_Open.

Here you can find a #tweetorial with a summary of the contents.
(1/7)

https://t.co/fbS9GDNw09

[chiara paratore @chiaramallow]

Will be a great opportunity to focus on the methodological aspect and risk of subgroup analyses in RCTs!

[Massimo Di Maio @MassimoDiMaio75]

For Italian colleagues, the @AIOMtweet
webinar on September 21 will be dedicated to the interpretation of subgroup analyses in clinical trials.
I'm sure it will be a stimulating discussion!

@clacardone @fperrone62 @chiaramallow

https://t.co/PQZwLlYVv1

[Claudia Cardone @clacardone]

🇮🇹 Interpretation of subgroup analyses in clinical trials
⏰ 21.09.22 - 17.00 via @AIOMtweet

@MassimoDiMaio75 will try again to make methodology easy 😵‍💫
@fperrone62 @SCinieri

👉🏻 🇮🇹 webinar registration
https://t.co/BviMNaiBQy

[d.planchard @dplanchard]

Advanced lung session overflow even in the overflow area … need larger room !#ESMO22 @myESMO

[Anna Maria Morelli @AnnaMar80406088]

Proud to share our work at ESMO2022!
#Nutrition
#cancer
#supportivecare

[chiara paratore @chiaramallow]

Taking care of patients affected by Lung Cancer with @WalceOnlus2006

Great presentation of Stefania Vallone at #ESMO2022

[WALCE APS @WalceOnlus2006]

🇬🇧EPROPA Project (promoted by WALCE) presented yesterday by Prof Silvia Novello (WALCE’s President) at #ESMO22 in #Paris.
🇮🇹È stato presentato ieri dalla Prof.ssa Silvia Novello al Congresso ESMO di Parigi, il progetto promosso da WALCE, EPROPA.
📲 https://t.co/9uALPthnJm

[chiara paratore @chiaramallow]

Being part of ESMO 2022

#proud #psychooncology #postersession #esmo2022

[Massimo Di Maio @MassimoDiMaio75]

Perception of sexuality disorders in cancer patients: A survey from Italian health providers https://t.co/Qb0ey94WVf

[Massimo Di Maio @MassimoDiMaio75]

More and more clinical trials in oncology use multiple primary endpoints.
How to read and interpret those results?
Hot off the press our systematic review.
@marialuciareale @fperrone62 @unito @OncoAlert

https://t.co/qRJSx7IxJa

[Luca Parmitano @astro_luca]

A #Catania vivono i miei genitori, mio fratello, parenti, i miei più cari amici. È una città rinata cento volte, da 2700 anni, tra terremoti o alluvioni: il suo cuore è un vulcano, la lava il suo sangue, la gente la sua linfa vitale - risorgerà ancora.

[chiara paratore @chiaramallow]

Gold is everywhere 🌾 https://t.co/oUebvALHDV